Matthew Vaughan

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

Tim Eisen, Chris Boshoff, Ian Mak et al. · British Journal of Cancer · 2000 · 342 citations · Full text

Medicine, Oncology, Pharmacology +13

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study

Mark Allen, Matthew Vaughan, Andrew Webb et al. · British Journal of Cancer · 2000 · 67 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cardiovascular and neuroendocrine responses to extended laboratory challenge.

Barbara S. McCann, Jennifer Carter, Matthew Vaughan et al. · Psychosomatic Medicine · 1993 · 53 citations

Medicine, Endocrinology, Physiology +17

Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?

Kalyan C. Latchamsetty, Lester S. Borden, Christopher R. Porter et al. · PubMed · 2007 · 53 citations

Medicine, Surgery, Urology +17

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high‐risk, locally advanced prostate cancer

Jacqueline Vuky, Christopher R. Porter, Christina Isacson et al. · Cancer · 2009 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17